Making progress

In the past month, headlines have indicated expansion of existing HIEs, increased rates of information exchange and rivals coming together to drive exchange.

During the most recent Health IT Policy Committee meeting, Michelle Consolazio, health IT policy analyst at the Office of the National Coordinator for Health IT, said hospital participation in the exchange of health information has grown significantly since 2008.

Consolazio presented survey research into overall trends and patterns of information exchange among office-based physicians and hospitals during 2013—prior to Meaningful Use Stage 2.

During this time, 40-50 percent of hospitals had the capability to query and send secure messages, with 51 percent able to query patient health information electronically and 41 percent able to send and receive secure messages with patient information to and from external sources, she said.

On the other hand, there is room for improvement as physician exchange activity with outside providers was limited in 2013, she said. Of every 10 physicians, four exchanged data electronically but the exchange of health information with an outside health system was limited. The majority of physicians reported benefits of exchange, especially in the areas of efficiency and quality of care, although many cited issues with multiple portals or systems and high costs.

But progress is progress and I think most of the healthcare industry welcomes both the existing exchange and efforts to drive more.

Beth Walsh

Clinical Innovation + Technology editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.